Motor disturbance and brain functional imaging in parkinson’s disease

European Neurology

Volumn 38, Issue , 1997, Pages 26-32

  Brooks, David J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dopamine; Fetal; Mesencephalic tissue; Motor disturbance; Parkinson s disease; Positron emission tomography; Transplants

Indexed keywords

AKINESIA; BRAIN TOMOGRAPHY; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; MOTOR DYSFUNCTION; NEURORADIOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE TRANSPLANTATION;

BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; ENERGY METABOLISM; FOLLOW-UP STUDIES; HUMANS; MOTOR SKILLS; NERVE REGENERATION; PARKINSON DISEASE; REGIONAL BLOOD FLOW; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0030696234     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113473     Document Type: Article

References (41)

1. Fimau G, Sood S, Chirakal R, Nahmias C, Garnett ES: Cerebral metabolism of 6-[18F]fluoro-L-3.4-dihydroxyphenylalanine in the primate, J Neurochcm 1987;48:1077-1082.
2. Chieuh CC, Bums RS, Kopin IJ, et al: 6-18F-Dopa/positron emission tomography visualized degree of damage to brain dopamine in basal ganglia of monkeys with MPTP-induced parkinsonism; in Markey SP, Castagnoli N, Trevor AJ, Kopin IJ (eds): MPTP: A Neurotoxin Producing a Parkinsonian Syndrome, Orlando, Academic Press, 1986. pp 327-338.
3. Garnett ES, Nahmias C, Fimau G: Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography, Can J Neurol Sei 1984:11:174-179.
4. Nahmias C, Garnett ES, Fimau G, Lang A: Striatal dopamine distribution in parkinsonian patients during life, J Neurol Sei 1985;69:223-230.
5. Lecnders KL, Palmer A, Turton D, et al: DOPA uptake and dopamine receptor binding visualized in the human brain in vivo; in Fahn S, Marsden CD, Jenner P, Teychenne P (eds): Recent Developments in Parkinson’s Disease, New York, Raven Press, 1986. pp 103-113.
6. l8F-dopa uptake in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy, Ann Neurol 1990:28:547-555.
7. Lecnders KL, Palmer AJ, Quinn N, et al: Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography, J Neurol Neurosurg Psychiatry 1986:49:853-860.
8. Martin WRW, Stoess IAJ, Adam MJ, et al: Positron emission tomography in Parkinson’s disease: Glucose and dopa metabolism, Adv Neurol 1986:45:95-98.
9. l8F]dopa PET findings in early Parkinson's disease, J Neurol Neurosurg Psychiatry 1995;59:597-600.
10. 18F-dopa PET in early and advanced Parkinson’s disease, Mov Disord 1996; 1l (suppl 1): 147.
11. Caine DB, Eisen A, McGeer EG, Spencer P: Alzheimer's disease, Parkinson’s disease and motoneurone disease: A biotrophic interaction between aging and environment, Lancet 1986; 1: 1067-1070.
12. Bhatt MH, Snow BJ, Martin WRW, Pate BD, Ruth TJ, Caine DB: Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow, Ann Neurol 1991:29:673-677.
13. Vingerhoets FJG, Snow BJ, Lee CS, Schützer M, Mak E, Caine DB: Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism, Ann Neurol 1994;36:759-764.
14. l8F]dopa PET and clinical study of the rate of progression in Parkinson's disease, Brain 1996: 119:585-591.
15. Feamlcv JM, Lees AJ: Ageing and Parkinson's disease: Substantia nigra regional selectivity, Brain 1991;114:2283-2301.
16. Vingerhoets FJG, Snow BJ, Schulzer M, et al: Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson’s disease, J Nucl Med 1996:37:421-426.
17. l8F]-6-/,-fluorodopa studies in two patients with putaminal implants, Ann Neurol 1992:31:166-173.
18. Lindvall O, Sawlc G, Widncr H, ct al: Evidence for long term survival and function of dopaminergic grafts in progressive Parkinson's disease, Ann Neurol 1994;35:172-180.
19. Widner H, Tetrud J, Rehncrona S, et al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-l, 2.3.6-tctrahydropvridine (MPTP), N Engl J Med 1992;327:1556-1563.
20. Freeman TB, Olanow CW, Hauser RA, et al: Bilateral fetal nigral transplantation into the post-commisural putamcn as a treatment for Parkinson’s disease: Six months follow-up, Ann Neurol 1995;38:379-388.
21. lsFjfluorodopa uptake in five grafted parkinsonian patients, Ann Neurol 1995;38:580-588.
22. Kordowcr JH, Freeman TB, Snow BJ, et al: Neuropathological evidence of graft survival and striatal rcinncrvation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease, N Engl J Med 1995; 332:1118-1124.
23. Crossman AR: A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson’s disease: Implications for future strategies in treatment, Mov Disord 1990:5:100-108.
24. Milctich RS, Chan T, Gillespie M, Di Chiro G, Stein S: Contralateral basal ganglia metabolism is abnormal in hemiparkinsonian patients, An FDG-PET study, Neurology 1988;38(suppl): 260.
25. Wolfson LI, Leenders KL, Brown, LL, JonesT: Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease, Neurology 1985;35:1399-1405.
26. Eidelberg D, Moeller JR, Dhawan V, et al: The metabolic topography of parkinsonism, J Cc-rcb Blood How Metab 1994; 14:783-801.
27. Leenders KL, Wolfson L, Gibbs JM, et al: The effects of L-dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson’s disease, Brain 1985:108:171-191.
28. Playford ED, Jenkins IH, Passingham RE, Nutt J, Fraekowiak RSJ, Brooks DJ: Impaired mesial frontal and putamen activation in Parkinson's disease: A PET study, Ann Neurol 1992:32:151-161.
29. Jahanshahi M, Jenkins IH, Brown RG, Mars-dcn CD, Passingham RE, Brooks DJ: Self-initiated versus externally triggered movements: Measurements of regional cerebral blood flow and movement-related potentials in normals and Parkinson’s disease, Brain 1995:118:913-933.
30. Thaler DE, Passingham RE: The supplementary motor cortex and internally directed movement: in Crossman AR, Sambrook M (eds): Neural Mechanisms in Disorders of Movement, London, Libby, 1989. pp 175-181.
31. Goldberg G: Supplementary motor area structure and function: Review and hypotheses, Be-hav Brain Sci 1985;8:567-616.
32. Samuel M, Ccballos-Baumann AO, Blin J, et al: Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements: A PET study, Brain 1997;120:963-976.
33. Jenkins IH, Fernandez W, Playford ED, et al: Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphinc, Ann Neurol 1992;32:749-757.
34. Rascol O, Sabatini U, Chollct F, et al: Supplementary and primary sensory motor area activity in Parkinson’s disease, Regional cerebral blood flow changes during finger movements and effects of apomorphine, Arch Neurol 1992: 49:144-148.
35. Rascol O, Sabatini U, Chollet F, et al: Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa, J Neurol Neurosurg Psychiatry 1994.57:567-571.
36. Ceballos-Baumann AO, Jenkins IH, Morrish PK, et al: Increase of movement-related activation of the supplementary motor area after embryonic mesencephalic grafting in Parkinson’s disease (abstract), Neurologv 1996;46(suppl):458.
37. Laitinen LV, Bergenheim AT, Hariz MI: Lek-sell’s posteroventral pallidotomy in the treatment ofParkinson’sdisease, J Neurosurg 1992: 76:53-61.
38. Ceballos-Baumann AO, Obcso JA, Delong MR, et al: Functional reafferentation of striatal-frontal connections after posteroventral pallidotomy in Parkinson's disease, Lancet 1994; 344:814.
39. lsO PET study, Brain 1997. in press
40. Grafton ST, Waters C, Sutton J, Lew MF, Couldwcl! W: Pallidotomy increases activity of motor association cortex in Parkinson’s disease: A positron emission tomographic study, Ann Neurol 1995;37:776-783.
41. Eidelberg D, Moeller JR, Ishikawa T, et al: Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson’s disease, Ann Neurol 1996:39:450